Menu

Matthew D. Silverman

Special Counsel

msilverman@cooley.com

Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.

Download full bio 

Experience

  • Amazon to Acquire One Medical for $3.9 Billion 

  • Digital Shadows Agrees to Sell to ReliaQuest 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 

  • View all

Practices & Industries

Passions

    Film, Music, Surfing and Travel

Education

  • Fordham University School of Law
    JD, cum laude, 2012

  • University of Vermont
    BA, Economics and Political Science
    Honors Program, 2006


Admissions & Credentials

California

New York